Erasca (ERAS) Equity Ratio (2020 - 2026)
Erasca posted quarterly Equity Ratio of 0.85 for Q1 2026, up 0.64% year-on-year from 0.85 in Q1 2025, and up 3.95% on a QoQ basis from 0.82 in Q4 2025.
Erasca (ERAS) has 7 years of Equity Ratio data on file, last reported at 0.85 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio rose 0.64% year-over-year to 0.85; the trailing twelve-month figure through Mar 2026 stood at 0.85 (up 0.64% YoY), and the FY2025 full-year result was 0.82, down 2.6% from the prior year.
- Equity Ratio for Q1 2026 stood at 0.85, up from 0.82 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.89 in Q1 2022 and bottomed at 0.78 in Q1 2024.
- The 5-year median for Equity Ratio is 0.83 (2025), against an average of 0.83.
- Peak annual rise in Equity Ratio reached 224.57% in 2022, while the deepest fall reached 12.15% in 2022.
- A 5-year view of Equity Ratio shows it stood at 0.8 in 2022, then increased by 0.16% to 0.8 in 2023, then advanced by 5.19% to 0.84 in 2024, then dropped by 2.6% to 0.82 in 2025, then climbed by 3.95% to 0.85 in 2026.
- The last three Equity Ratio figures came in at 0.85 (Q1 2026), 0.82 (Q4 2025), and 0.83 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.73 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.77 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.21 |
| 10 | Erasca | 4.21 Bn | 3.97 Bn | - | 0.85 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.85 |
| Dec 31, 2025 | 0.82 |
| Sep 30, 2025 | 0.83 |
| Jun 30, 2025 | 0.84 |
| Mar 31, 2025 | 0.85 |
| Dec 31, 2024 | 0.84 |
| Sep 30, 2024 | 0.85 |
| Jun 30, 2024 | 0.86 |
| Mar 31, 2024 | 0.78 |
| Dec 31, 2023 | 0.80 |
| Sep 30, 2023 | 0.81 |
| Jun 30, 2023 | 0.82 |
| Mar 31, 2023 | 0.83 |
| Dec 31, 2022 | 0.80 |
| Sep 30, 2022 | 0.82 |
| Jun 30, 2022 | 0.89 |
| Mar 31, 2022 | 0.89 |
| Dec 31, 2021 | 0.91 |
| Sep 30, 2021 | 0.93 |
| Jun 30, 2021 | -0.71 |
| Dec 31, 2020 | -0.91 |